About Congenica
Congenica is a company based in Cambridge (United Kingdom) founded in 2013 by Nick Lench, Richard Durbin, and Matthew Hurles was acquired by SeqOne in September 2025.. Congenica has raised $81.91 million across 11 funding rounds from investors including Tencent, BGI and Downing. The company has 79 employees as of December 31, 2020. Congenica offers products and services including Congenica Platform and Clinical Interpretation Services. Congenica operates in a competitive market with competitors including Denali Therapeutics, MiRagen, Poseida Therapeutics, Castle Biosciences and Unity Biotechnology, among others.
- Headquarter Cambridge, United Kingdom
- Employees 79 as on 31 Dec, 2020
- Founders Nick Lench, Richard Durbin, Matthew Hurles
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Congenica Ltd
- Date of Incorporation 30 Oct, 2012
- Jurisdiction CAMBRIDGE, ENGLAND
-
Annual Revenue
$6.06 M (USD)15as on Dec 31, 2023
-
Net Profit
$-13.94 M (USD)17as on Dec 31, 2023
-
EBITDA
$-14.89 M (USD)18as on Dec 31, 2023
-
Total Equity Funding
$81.91 M (USD)
in 11 rounds
-
Latest Funding Round
$2.81 M (USD), Grant
Jun 17, 2021
-
Investors
Tencent
& 18 more
-
Employee Count
79
as on Dec 31, 2020
-
Acquired by
SeqOne
(Sep 02, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Congenica
Congenica offers a comprehensive portfolio of products and services, including Congenica Platform and Clinical Interpretation Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Software for automated genomic data analysis and interpretation
Services for interpreting genetic data in clinical settings
Unlock access to complete
Unlock access to complete
Funding Insights of Congenica
Congenica has successfully raised a total of $81.91M across 11 strategic funding rounds. The most recent funding activity was a Grant round of $2.81 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Grant — $2.8M
-
First Round
First Round
(02 May 2014)
- Investors Count 18
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Grant - Congenica | Valuation |
investors |
|
| Nov, 2020 | Amount | Series C - Congenica | Valuation | Tencent , Legal & General | |
| Apr, 2019 | Amount | Series B - Congenica | Valuation | Parkwalk |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Congenica
Congenica has secured backing from 19 investors, including institutional and venture fund investors. Prominent investors backing the company include Tencent, BGI and Downing. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm
|
Founded Year | Domain | Location | |
|
Health and technology startups are invested in by Puhua Capital.
|
Founded Year | Domain | Location | |
|
Startups are targeted for investments by this venture capital firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Congenica
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Congenica
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Congenica Comparisons
Competitors of Congenica
Congenica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, MiRagen, Poseida Therapeutics, Castle Biosciences and Unity Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for multiple health purposes
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Congenica
Frequently Asked Questions about Congenica
When was Congenica founded?
Congenica was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Congenica located?
Congenica is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Who is the current CEO of Congenica?
Rob Denison is the current CEO of Congenica.
Is Congenica a funded company?
Congenica is a funded company, having raised a total of $81.91M across 11 funding rounds to date. The company's 1st funding round was a Series B of $17.13M, raised on May 02, 2014.
How many employees does Congenica have?
As of Dec 31, 2020, the latest employee count at Congenica is 79.
What is the annual revenue of Congenica?
Annual revenue of Congenica is $6.06M as on Dec 31, 2023.
What does Congenica do?
Congenica was founded in 2013 and is based in Cambridge, United Kingdom. The company operates in the genomics and healthcare sector, providing a platform for clinical genome analytics. This platform enables detection of complex mutations, filtering of clinically relevant variants, and deep phenotyping. Client data is organized with a focus on outcomes, stored securely, and integrated through intuitive tools for interrogation and sharing.
Who are the top competitors of Congenica?
Congenica's top competitors include Geneoscopy, Poseida Therapeutics and Denali Therapeutics.
What products or services does Congenica offer?
Congenica offers Congenica Platform and Clinical Interpretation Services.
Who are Congenica's investors?
Congenica has 19 investors. Key investors include Tencent, BGI, Downing, SeqOne, and Legal & General.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.